サマリー

市場の分析と洞察。遺伝子組換えヒト凝固VIIaの世界市場および中国市場
COVID-19の大流行により、遺伝子組換えヒト凝固VIIaの世界市場規模は2022年に1180百万米ドルと推定され、予測期間2022-2028年にはCAGR3.7％で2028年までに1467百万米ドルの再調整サイズとなると予測されています。
2021年の中国遺伝子組み換えヒト凝固VIIaの市場規模は2910万米ドル、北米は5億726万米ドルでした。2021年の中国の比率は2.57％、北米の比率は44.74％でした。
組み換えヒト凝固VIIaの世界の主要メーカーは、Novo Nordisk、GENERIUM 、LFB SA HEMA Biologics、AryoGen Pharmedなどである。収益面では、2021年の遺伝子組換えヒト凝固VIIaの市場シェアは、世界3大企業が99.16％を占めています。

遺伝子組換えヒト凝固VIIaの世界的な範囲と市場規模
遺伝子組換えヒト凝固VIIa市場は、地域（国）別、プレイヤー別、タイプ別、用途別に分類されます。世界の遺伝子組み換えヒト凝固VIIa市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てます。

中国市場については、2017-2028年までの遺伝子組換えヒト凝固VIIaのプレイヤー別、タイプ別、アプリケーション別の市場規模に焦点を当てます。主要プレイヤーには、中国で重要な役割を果たすグローバルプレイヤーおよびローカルプレイヤーが含まれます。

世界の遺伝子組換えヒト凝固VIIa市場で事業を展開している主要メーカーは以下の通りです。
ノボノルディスク
ジェネリアム
LFB SA HEMA バイオロジックス
アーリオジェン・ファーマド

タイプ別セグメント
バイアル
プレフィルドシリンジ

用途別セグメント
先天性血友病
後天性血友病
その他

地域別セグメント
北アメリカ
欧州
日本・韓国
中国
インド
ラテンアメリカ

ページTOPに戻る

目次

1 MARKET OVERVIEW 1
1.1 Recombinant Human Coagulation VIIa Product Introduction and Study Scope 1
1.2 Market by Type 2
1.2.1 Global Recombinant Human Coagulation VIIa Market Size Growth Rate by Type 2
1.2.2 Vial 3
1.2.3 Prefilled Syringe 4
1.3 Market by Application 4
1.3.1 Global Recombinant Human Coagulation VIIa Market Size Growth Rate by Application 5
1.3.2 Congenital Hemophilia 6
1.3.3 Acquired Hemophilia 6
1.4 Recombinant Human Coagulation VIIa Industry Background, History, Status and Forecast 7
1.4.1 Recombinant Human Coagulation VIIa Industry Status 7
1.4.2 Recombinant Human Coagulation VIIa Industry Trends 7
2 GLOBAL RECOMBINANT HUMAN COAGULATION VIIA MARKET SIZE 9
2.1 Global Recombinant Human Coagulation VIIa Supply and Demand, (2017-2028) 9
2.1.1 Global Recombinant Human Coagulation VIIa Capacity, Production, Capacity Utilization, Status and Forecast, 2017-2028 9
2.1.2 Global Recombinant Human Coagulation VIIa Production by Region: 2017-2022 10
2.2 Global Recombinant Human Coagulation VIIa Sales and Revenue 12
2.2.1 Global Recombinant Human Coagulation VIIa Revenue, (2017-2028) 12
2.2.2 Global Recombinant Human Coagulation VIIa Sales, 2017-2028 14
2.2.3 Global Recombinant Human Coagulation VIIa Price, 2017-2028 15
3 COMPETITION BY MANUFACTURERS 16
3.1 Global Recombinant Human Coagulation VIIa Sales by Manufacturers 16
3.1.1 Global Recombinant Human Coagulation VIIa Sales by Manufacturer (2017-2022) 16
3.1.2 Global Recombinant Human Coagulation VIIa Revenue by Manufacturer (2017-2022) 17
3.1.3 Global Manufacturers Ranked by Recombinant Human Coagulation VIIa Revenue 18
3.1.4 Global Recombinant Human Coagulation VIIa Sales Price by Manufacturers 18
3.2 China Recombinant Human Coagulation VIIa Sales by Manufacturer 18
3.2.1 China Recombinant Human Coagulation VIIa Sales by Manufacturer (2017-2022) 18
3.2.2 China Recombinant Human Coagulation VIIa Revenue by Manufacturer (2017-2022) 19
3.2.3 China Manufacturers Ranked by Recombinant Human Coagulation VIIa Revenue 20
3.2.4 China Recombinant Human Coagulation VIIa Sales Price by Manufacturers 20
3.3 Recombinant Human Coagulation VIIa Manufacturing Base Distribution and Headquarters 20
3.4 Manufacturers Recombinant Human Coagulation VIIa Product Offered 21
3.5 Analysis of Competitive Landscape 22
3.5.1 Global Top 3 Companies by Recombinant Human Coagulation VIIa Revenue in 2021 22
3.5.2 Global Recombinant Human Coagulation VIIa Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 22
3.6 Mergers & Acquisitions, Expansion Plans 23
4 GLOBAL RECOMBINANT HUMAN COAGULATION VIIA ANALYSIS BY REGION 24
4.1 Global Recombinant Human Coagulation VIIa Revenue by Region: 2017 VS 2021 VS 2028 24
4.1.1 Global Top Recombinant Human Coagulation VIIa Regions by Revenue 26
4.1.2 Global Top Recombinant Human Coagulation VIIa Regions by Revenue (2023-2028) 27
4.2 Global Top Recombinant Human Coagulation VIIa Regions by Sales: 2017 VS 2021 VS 2028 28
4.2.1 Global Top Recombinant Human Coagulation VIIa Regions by Sales (2017-2022) 28
4.2.2 Global Top Recombinant Human Coagulation VIIa Regions by Sales (2023-2028) 30
4.3 North America Recombinant Human Coagulation VIIa Sales & Revenue (2017-2028) 32
4.4 Europe Recombinant Human Coagulation VIIa Sales & Revenue (2017-2028) 34
4.5 China Recombinant Human Coagulation VIIa Sales & Revenue (2017-2028) 36
4.6 Japan & Korea Recombinant Human Coagulation VIIa Sales & Revenue (2017-2028) 38
4.7 Latin America Recombinant Human Coagulation VIIa Sales & Revenue (2017-2028) 40
4.8 India Recombinant Human Coagulation VIIa Sales & Revenue (2017-2028) 42
5 CORPORATE PROFILE 43
5.1 Novo Nordisk 43
5.1.1 Novo Nordisk Corporation Information 43
5.1.2 Novo Nordisk Overview 43
5.1.3 Novo Nordisk Recombinant Human Coagulation VIIa Sales, Price, Revenue and Gross Margin (2017-2022) 44
5.1.4 Novo Nordisk Recombinant Human Coagulation VIIa Product Description 44
5.1.5 Novo Nordisk Recent Developments 47
5.2 LFB SA HEMA Biologics 48
5.2.1 LFB SA HEMA Biologics Corporation Information 48
5.2.2 LFB SA HEMA Biologics Overview 48
5.2.3 LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Sales, Price, Revenue and Gross Margin (2017-2022) 49
5.2.4 LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Product Description 49
5.2.5 LFB SA HEMA Biologics Recent Developments 50
5.3 AryoGen Pharmed 51
5.3.1 AryoGen Pharmed Corporation Information 51
5.3.2 AryoGen Pharmed Overview 51
5.3.3 AryoGen Pharmed Recombinant Human Coagulation VIIa Sales, Price, Revenue and Gross Margin (2017-2022) 52
5.3.4 AryoGen Pharmed Recombinant Human Coagulation VIIa Product Description 52
5.4 GENERIUM 54
5.4.1 GENERIUM Corporation Information 54
5.4.2 GENERIUM Overview 54
5.4.3 GENERIUM Recombinant Human Coagulation VIIa Sales, Price, Revenue and Gross Margin (2017-2022) 55
5.4.4 GENERIUM Recombinant Human Coagulation VIIa Product Description 55
6 MARKET SIZE BY TYPE 57
6.1 Global Recombinant Human Coagulation VIIa Sales by Type 57
6.1.1 Global Recombinant Human Coagulation VIIa Historical Sales by Type (2017-2022) 57
6.1.2 Global Recombinant Human Coagulation VIIa Forecasted Sales by Type (2023-2028) 57
6.1.3 Global Recombinant Human Coagulation VIIa Sales Market Share by Type (2017-2028) 58
6.2 Global Recombinant Human Coagulation VIIa Revenue by Type 59
6.2.1 Global Recombinant Human Coagulation VIIa Historical Revenue by Type (2017-2022) 59
6.2.2 Global Recombinant Human Coagulation VIIa Forecasted Revenue by Type (2023-2028) 59
6.2.3 Global Recombinant Human Coagulation VIIa Revenue Market Share by Type (2017-2028) 59
6.3 Global Recombinant Human Coagulation VIIa Price by Type 60
6.3.1 Global Recombinant Human Coagulation VIIa Price by Type (2017-2022) 60
6.3.2 Global Recombinant Human Coagulation VIIa Price Forecast by Type (2023-2028) 61
7 MARKET SIZE BY APPLICATION 62
7.1 Global Recombinant Human Coagulation VIIa Sales by Application 62
7.1.1 Global Recombinant Human Coagulation VIIa Historical Sales by Application (2017-2022) 62
7.1.2 Global Recombinant Human Coagulation VIIa Forecasted Sales by Application (2023-2028) 62
7.1.3 Global Recombinant Human Coagulation VIIa Sales Market Share by Application (2017-2028) 63
7.2 Global Recombinant Human Coagulation VIIa Revenue by Application 64
7.2.1 Global Recombinant Human Coagulation VIIa Historical Revenue by Application (2017-2022) 64
7.2.2 Global Recombinant Human Coagulation VIIa Forecasted Revenue by Application (2023-2028) 65
7.2.3 Global Recombinant Human Coagulation VIIa Revenue Market Share by Application (2017-2028) 65
7.3 Global Recombinant Human Coagulation VIIa Price by Application 66
7.3.1 Global Recombinant Human Coagulation VIIa Price by Application (2017-2022) 66
7.3.2 Global Recombinant Human Coagulation VIIa Price Forecast by Application (2023-2028) 67
8 UPSTREAM RAW MATERIALS AND DOWNSTREAM ANALYSIS 68
8.1 Recombinant Human Coagulation VIIa Industry Chain Analysis 68
8.2 Recombinant Human Coagulation VIIa Key Raw Materials 69
8.2.1 Key Raw Materials 69
8.2.2 Raw Materials Key Suppliers 69
8.3 Recombinant Human Coagulation VIIa Typical Customers 70
8.4 Recombinant Human Coagulation VIIa Sales Channels 73
9 RECOMBINANT HUMAN COAGULATION VIIA MARKET DYNAMICS 78
9.1 Recombinant Human Coagulation VIIa Industry Trends 78
9.2 Recombinant Human Coagulation VIIa Market Drivers 79
9.3 Recombinant Human Coagulation VIIa Market Challenges 80
9.4 Recombinant Human Coagulation VIIa Market Restraints 80
10 RESEARCH FINDINGS AND CONCLUSION 81
11 METHODOLOGY AND DATA SOURCE 83
11.1 Methodology/Research Approach 83
11.1.1 Research Programs/Design 83
11.1.2 Market Size Estimation 84
11.1.3 Market Breakdown and Data Triangulation 85
11.2 Data Source 86
11.2.1 Secondary Sources 86
11.2.2 Primary Sources 87
11.3 Author List 89
11.4 Disclaimer 90